Clear overexpression is seen in tumors that have metabolically active oxidative environments, such as hepatocellular carcinoma, renal cell carcinoma or non-small cell lung adenocarcinoma, while in some malignancies, such as multiple myeloma, fewer than half cancerous cells were showing MTH1 overexpression. Here, NUDT1 is linked to plasma cell myeloma.